7Indexed trials
drug · Product Intelligence
Oxytocin
Pipeline Intelligence
Oxytocin: 7 indexed trials, 6 sponsors; 0 linked Orange Book patents and 9 FDA-linked events where matched.
6Sponsors
0Orange Book patent links
9FDA-linked events
Development evidence
NCT00263796Anagnostou, Evdokia, M.D. · autismPHASE1
NCT01308749University of North Carolina, Chapel Hill · autismPHASE2
NCT01573273Medical University of South Carolina · substance_useNA
NCT01621737University of California, San Diego · schizophreniaNA
NCT01827332Medical University of South Carolina · substance_useNA
NCT02824627University of Nebraska · adhdPHASE2
NCT02918864Rush University Medical Center · autismPHASE2
FDA / patent evidence
Orange Book match found; no listed patent relation was retained for this product match.
Regulatory context
FDA_APPROVALOXYTOCIN · 2018-07-13
FDA_APPROVALOXYTOCIN · 2013-02-13
FDA_APPROVALPITOCIN · 2012-09-05
FDA_APPROVALOXYTOCIN · 2008-01-24
FDA_APPROVALOXYTOCIN · 2007-07-27
FDA_APPROVALOXYTOCIN · 2007-01-10
FDA_APPROVALOXYTOCIN 20 USP UNITS IN DEXTROSE 5% · 1985-03-29
FDA_APPROVALSYNTOCINON ·
FDA_APPROVALSYNTOCINON ·
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.